Several Options Remain For Cidara’s Flu Candidate After J&J Halts Development

hands holding up a paper cut-out showing arrows in different directions
Janssen Could Out-License The Asset Or Return It To Cidara • Source: Shutterstock

More from Business

More from Scrip